Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...

A new request by Ozempic manufacturer Novo Nordisk could limit the availability of a type of GLP-1—semaglutides—to local ...

A new weight loss service offering GLP-1 injections has been launched. Vertis Health, based in Worcestershire, has introduced ...

The "Oral Care Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering. The oral ...

It should insist on finishing what Gov. Katie Hobbs set out to do in January 2023, when she appointed retired Judge David ...

Platforms like BigBasket and Blinkit are disrupting the sector with quick medicine deliveries and ambulance, shaping the ...

Some people are microdosing certain weight loss drugs in an attempt to reap some of the drugs' benefits with fewer of their side effects. But doctors specializing in weight loss say that ...

The results are an uncomfortable echo of late October 2024, when Mounjaro and Zepbound missed by similar margins. Those ...

Analyze the market shares of key market participants offering probiotic-enhanced products, their research priorities, product ...

The healthcare industry is rapidly integrating artificial intelligence (AI)-powered solutions in various verticals to achieve higher operational & clinical outcomes, which is a key contributing factor ...